Role of TAB1 in nitric oxide-induced p38 activation in insulin-producing cells

International Journal of Biological Sciences

Volumn 3, Issue 2, 2007, Pages 71-76

  Makeeva, Natalia ^a   Roomans, Godfried M ^a   Welsh, Nils ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Insulin producing cell; Nitric oxide; p38 MAPK; TAB1

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOPHOSPHORYLATION; CELL DEATH; CLONING; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 33846929880     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3.71     Document Type: Article

References (39)

1. Eizirik DL, and Pavlovic D. Is there role for NO in β-cell dysfunction and damage in IDDM? Diabetes/metab Rev 1997; 13: 293-307.
2. Welsh N, Eizirik DL, Bendtzen K, et al. Interleukin-1β-induced NO production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 1991; 129: 3167-73.
3. Pavlovic D, Chen MC, Bouwens L, et al. Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes 1999; 48: 29-33.
4. Kroncke KD, Kolb-Bachofen V, Berschick B, et al. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent NO generation. Biochem Biophys Res Commun 1991; 175: 752-8.
5. Steiner L, Kroncke K, Fehsel K, et al. Endothelial cells as cytotoxic effector cells: cytokine-activated rat islet endothelial cells lyse syngeneic islet cells via NO. Diabetologia 1997; 40: 150-5.
6. Estevez AG, and Jordan J. NO and superoxide, a deadly cocktail. Ann NY Acad Sci 2002; 962: 207-11
7. Chung HT, Pae HO, Choi BM, et al. NO as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001; 282: 1075-9.
8. Umansky V, and Schirrmacher V. NO-induced apoptosis in tumor cells. Adv Cancer Res 2001; 82: 107-31
9. Lau HK. Cytotoxicity of NO donors in smooth muscle cells is dependent on phenotype, and mainly due to apoptosis. Atherosclerosis 2002; 166: 223-32
10. Barbu AR, Welsh N, Saldeen J. Cytokine-induced apoptosis and necrosis are preceded by disruption of the mitochondrial membrane potential in pancreatic RINm5F cells: prevention by Bcl-2. Mol Cell Endocrinol 2002; 190: 75-82.
11. Saldeen J, Tilmar L, Karlsson E, et al. Nicotinamide- and caspase-mediated inhibition of poly(ADP-ribose) polymerase are associated with p53-independent cell cycle (G2) arrest and apoptosis. Mol Cell Bioch 2003; 243: 113-22.
12. Cardozo AK, Ortis F, Storling J, et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells. Diabetes 2005; 54: 452-61.
13. Larsen CM, Wadt KA, Juhl LF, et al. Interleukin-1beta-induced rat pancreatic islet NO synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem 1998; 273: 15294-300.
14. Saldeen J, Lee JC, Welsh N. Role of p38 MAPK in cytokine-induced rat islet cell apoptosis. Biochem Pharmacol 2001; 61: 561-9.
15. Storling J, Binzer J, Andersson AK, et al. NO contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition Akt. Diabetologia 2005; 48: 2039-50.
16. Ammendrup A, Maillard A, Nielsen K, et al. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes 2000; 49: 1468-76.
17. Bonny C, Oberson A, Negri S, et al. Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes 2001; 50: 77-82.
18. Aikin R, Maysinger D, and Rosenberg L. Cross-talk between PI3K/AKT and JNK mediates survival of isolated human islets. Endocrinology 2004; 145: 4522-31.
19. Eckhoff DE, Smyth CA, Eckstein C, et al. Suppression of the c-JNK N-terminal kinase pathway by 17-beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction. Surgery 2003; 134: 169-79.
20. Makeeva N, Myers JW, and Welsh N. Role of MKK3 and p38 MAPK in cytokine-induced death of insulin producing cells. Biochem. J. 2006;393: 129-39.
21. Ge B, Gram H, Di Padova F, et al. MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science 2002; 295: 1291-4.
22. Ge B, Xiong X, Jing Q, et al. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1 beta), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J Biol Chem 2003; 278: 2286-93.
23. Shibuya H, Yamaguchi K, Shirakabe K, et al. TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 1996; 272: 1179-82.
24. Ono K, Ohtomo T, Sato S, et al. An evolutionarily conserved motif in the TAB1 C-terminal region is necessary for interaction with and activation of TAK1 MAPKKK. J Biol Chem 2001; 276: 24396-400.
25. Welsh N. Assessment of apoptosis and necrosis in isolated islets of Langerhans: methodological considerations. Curr Top Biochem Res 2000; 2: 189-200.
26. Flodstrom M, Tyrberg B, Eizirik DL, et al. Reduced sensitivity of inducible NO synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 1999; 48: 706-13.
27. Mandrup-Poulsen T. β-cell apoptosis: stimuli and signaling. Diabetes 2001; 50: S58-S63
28. Kay TW, Thomas HE, Harrison LC, et al. The β-cells in autoimmune diabetes: many mechanisms and pathways of loss. Trends Endocrinol Metab 2000; 11: 11-5.
29. Thomas HE, and Kay TW. How β cells die in type 1 diabetes. Curr Direct Autoimmun 2001; 4: 144-70.
30. Takamura T, Kato I, Kimura N, et al. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis. J Biol Chem 1998; 273: 2493-6.
31. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, et al. Human pancreatic islet β-cell destruction by cytokines is independent of NO production. J Clin Endocrinol Metab 1994; 79: 1058-62.
32. Eizirik DL, Sandler S, Welsh N, et al. Cytokines suppress human islet function irrespective of their effects on NO generation. J Clin Invest 1994; 93: 1968-74.
33. Scarim AL, Nishimoto SY, Weber SM, et al. Role for c-Jun N-terminal kinase in β-cell recovery from NO-mediated damage. Endocrinology 2003; 144: 3415-22.
34. Bernabe JC, Tejedo JR, Rincon P, et al. Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RIN5mF cells are associated with MAP kinases activation. Exp Cell Res 2001; 269: 222-9.
35. Cheung P, Campbell D, Nebreda A, et al. Feedback control of the protein kinase TAK1 by SAPK2α/p38α. EMBO J 2003; 21: 793-805
36. Cuenda A, Rouse J, Doza YN, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995; 364: 229-33.
37. Jeon HK, Choi S, and Jung NP. Association of the ERK1/2 and p38 kinase pathways with NO-induced apoptosis and cell cycle arrest in colon cancer cells. Cell Biol Tox 2005; 21: 115-25.
38. Kang YI, and Chae SW. JNK/SAPK is required in NO induced apoptosis in osteoblasts. Arch Pharm Res 2003; 26: 937-42.
39. Ajizian SJ, English BK, and Meals EA. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible NO synthase and tumor-necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. J Infec Dis 1999; 179: 939-44.